- On a call with investors this week, GW Pharmaceuticals revealed the price of Epidiolex, its newly-approved, marijuana-based drug for rare forms of epilepsy.
- Designed to treat two rare forms of childhood epilepsy using a marijuana compound called CBD, the drug is the first medication of its kind to get FDA approval.
- The person leading the company's commercialization efforts in the US said the goal is to keep the price of the drug on par with other epilepsy medications.
A marijuana-derived drug that recently became the first of its kind to win federal approval is not going to be cheap.
Called Epidiolex, the drug is designed to treat two rare forms of childhood epilepsy using a cannabis compound called cannabidiol (or CBD).
See the rest of the story at Business Insider
NOW WATCH: What happens when you hold in your pee for too long
See Also:
- Heineken is betting on a brew made with marijuana instead of alcohol, and it could help give a boost to the struggling beer industry
- The billionaire heir to a chewing gum fortune is making a huge bet on marijuana
- An artist found an inch-long parasitic worm in his eye — and created a haunting image
DON'T MISS: There’s a sea change coming for the $1 billion marijuana-based industry you’ve never heard of
from Business Insider https://ift.tt/2vujnHV
No comments:
Post a Comment